6-fluoro-2-(1-methyl-1h-indol-5-yl)benzo[d]thiazole

**6-fluoro-2-(1-methyl-1h-indol-5-yl)benzo[d]thiazole** is a synthetic small-molecule compound belonging to the benzothiazole class, designed as a selective, reversible inhibitor of monoamine oxidase B (MAO-B). It exhibits high potency (IC50 = 28 nM) and specificity for MAO-B over MAO-A, making it a promising neuropharmacological agent for the treatment of Parkinson's disease. In preclinical studies, the compound demonstrated *neuroprotective effects in animal models*, oral bioavailability, favorable liver microsomal stability, and a lack of significant CYP isozymes inhibition, indicating low risk for drug-drug interactions. The design incorporates an indole moiety for selectivity and optimal pharmacokinetic properties, resulting in full reversibility and minimal off-target activity[2].